Skip to main content

Table 1

From: Assessment of left ventricular systolic and diastolic function in patients with sarcoidosis with and without cardiac involvement by magnetic resonance feature tracking at 1.5T: a follow up study

  Initial exam        
  PSSR PDSR PSECC EDSR Age (y) LVEF (%) LVEDV (ml) IVSD (mm)
Group1 (n= 14) -1,09 ± 0,75 1,14 ± 0,35 -18,43 ± 4,27 53,24 ± 15,26 50,57 ± 13,51 62,15 ± 8,87 120 ± 24,42 10,63 ± 1,66
Group2 (n = 9) -1,49 ± 0,37 1,42 ± 0,42 -22,21 ± 6,47 75,1 ± 22,62 51,89 ± 5,88 68,33 ± 7,75 106,33 ± 6 10,69 ± 1,69
Group3 (n = 37) -1,51 ± 0,39 1,36 ± 0,1 -24,33 ± 3,5 77,25 ± 5,06 50,78 ± 12,66 64,84 ± 4,76 116,53 ± 31,64 9,47 ± 1,62
Group4 (n = 20) -1,51 ± 0,28 1,37 ± 0,48 -24,53 ± 4,38 79,74 ± 25,59 59,32 ± 28,99 61,88 ± 7,07 135,99 ± 9,19 9,7 ± 1,84
   Significance (p-value)       
Group1 vs. Group2 0,1813 0,1153 0,1132 0,0133     
Group1 vs. Group3 0,0105 0,1440 0,0010 0,0006     
Group1 vs. Group4 0,0248 0,1347 0,0002 0,0014     
  1. FT results of group 1-4 including 2-tailed t-test results and patient characteristics.